
-
Jaiswal confident India can spoil England bid for series-winning chase
-
Rovanpera survives puncture to close in on home win in Finland Rally
-
Siraj strikes after Jaiswal helps India set England daunting target
-
Doncic inks three-year $165 mln Lakers extension
-
Hamilton feeling 'useless' after Hungarian GP qualifying flop
-
Elation as pope arrives by helicopter to open-air youth vigil in Rome
-
McLaren blown away by changing wind as Leclerc lands pole for Ferrari
-
Home hero Ferrand-Prevot in epic climb to Tour de France lead
-
Leclerc ends Ferrari barren run with stunning pole ahead of McLarens
-
Ferrari's Leclerc on pole for Hungarian GP
-
Jaiswal's hundred leaves England needing Oval-record chase to beat India
-
At open-air Church party, many thousands of young Catholics eagerly await pope
-
Schmidt hails 'grit and resilience' as his Wallabies upset Lions
-
Dmitry Medvedev: Russia's hawkish ex-president
-
Imperious Ledecky beats McIntosh to win 800m free thriller
-
Ledecky reigns over McIntosh as record-breaking US hit back at critics
-
Farrell says 'dream' Lions should be proud despite bitter defeat
-
Ledecky beats McIntosh to win 800m freestyle thriller
-
Fearless Wallabies stun weary Lions to win third Test 22-12
-
Double champion Walsh calls Phelps criticism 'frustrating'
-
Jaiswal and Deep keep India in the hunt against England
-
Piastri edges Norris as McLaren dominate Hungarian GP final practice
-
US envoy meets Israeli hostage families in Tel Aviv
-
McKeown beats Smith again for world backstroke double
-
New dad McEvoy adds 'unreal' world swimming gold to Olympic title
-
Walsh completes world butterfly double in riposte to Phelps
-
Turkey starts supplying Azerbaijani gas to boost Syria's power output
-
Thousands of young Catholics converge for grand Pope Leo vigil
-
SpaceX Crew Dragon docks with International Space Station
-
New push to reach plastic pollution pact
-
US do talking in pool after Phelps, Lochte slam worlds performance
-
Up to a million young Catholics expected for grand Pope Leo vigil
-
New push to reach plastic polution pact
-
Second seed Fritz ends Canadian hopes at ATP Toronto Masters
-
Japan sweats through hottest July on record
-
Jefferson-Wooden, Bednarek blaze to 100m titles at US trials
-
Son Heung-min to leave Tottenham this summer after decade
-
Richardson 'domestic violence' drama overshadows US trials
-
Bid to relocate US Space Shuttle Discovery faces museum pushback
-
Academics warn Columbia University deal sets dangerous precedent
-
Sevastova topples Pegula to book date with Osaka, Swiatek advances in Montreal
-
Former Olympic champion Mu-Nikolayev fails in worlds bid
-
Sensible and steely: how Mexico's Sheinbaum has dealt with Trump
-
Young leads at weather-hit PGA Wyndham Championship
-
US sprint star Richardson out of trials following arrest
-
Rublev, Tiafoe sweat out three-set wins in Toronto
-
Ex-porn actor to be Colombian equality minister
-
Olympic swim greats Phelps, Lochte, rip US World Championships performance
-
Brazilians burn Trump effigies as tariffs spark anger
-
Global stocks fall sharply on weak US job data, Trump tariffs
RBGPF | 0% | 74.94 | $ | |
CMSC | 0.09% | 22.87 | $ | |
NGG | 1.99% | 71.82 | $ | |
RELX | -0.58% | 51.59 | $ | |
SCS | -1.47% | 10.18 | $ | |
CMSD | 0.34% | 23.35 | $ | |
RIO | -0.2% | 59.65 | $ | |
RYCEF | 0.07% | 14.19 | $ | |
BTI | 1.23% | 54.35 | $ | |
GSK | 1.09% | 37.56 | $ | |
VOD | 1.37% | 10.96 | $ | |
JRI | -0.23% | 13.1 | $ | |
AZN | 1.16% | 73.95 | $ | |
BCE | 1.02% | 23.57 | $ | |
BP | -1.26% | 31.75 | $ | |
SCU | 0% | 12.72 | $ | |
BCC | -0.55% | 83.35 | $ |

US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
G.AbuGhazaleh--SF-PST